Literature DB >> 19137263

Comparison of 90-s versus 5-min intraoperative 5-fluorouracil in trabeculectomy.

Andrea Zarkovic1, Kent Chow, Justin S Mora.   

Abstract

To compare the relative efficacy of trabeculectomy surgery with 90-s and 5-min intraoperative exposure time to 5-fluorouracil. This was a retrospective, non-randomized comparative study. 41 eyes of 33 consecutive patients in the study group were compared to 40 eyes of 30 consecutive patients in the historical control group. Both groups were exposed to 5-fluorouracil (50 mg/ml) during trabeculectomy surgery. The exposure time was 90 s for the study group and 5 min for the control group. Three criteria were used to define surgical success: IOP (intraocular pressure) less than 21 mmHg; IOP less than 21 mmHg with more than 30% reduction in pressure; and IOP less than 15 mmHg with more than 30% reduction. The number of antiglaucoma medications, visual acuity, complications, and interventions were recorded at regular intervals. Mean preoperative IOP was 21.6 +/- 4.8 in the 90-s group and 21.2 +/- 4.9 in the 5-min group. Mean follow-up was 28.2 +/- 5.1 months in the 90-s group and 48.0 +/- 4.9 months in the 5-min group. During the first 30 postoperative months, there were no statistically significant differences in IOP and requirement for antiglaucoma medications between the two groups. The 90-s group had shorter survival rates using the 1st success criteria, but no significant difference was detected when the more stringent 2nd and 3rd criteria were applied. Choroidal effusions were significantly less common in the 90-s group (P = 0.0076). The results of this small study suggest that a 90-s application of 5-fluorouracil may be as effective as a 5-min one in trabeculectomy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137263     DOI: 10.1007/s10792-008-9287-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  25 in total

1.  Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.

Authors:  K Singh; K Mehta; N M Shaikh; J C Tsai; M R Moster; D L Budenz; D S Greenfield; P P Chen; J S Cohen; G S Baerveldt; S Shaikh
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma.

Authors:  M F Smith; M B Sherwood; J W Doyle; P T Khaw
Journal:  Am J Ophthalmol       Date:  1992-12-15       Impact factor: 5.258

Review 3.  Ciliochoroidal detachment.

Authors:  R F Brubaker; J E Pederson
Journal:  Surv Ophthalmol       Date:  1983 Mar-Apr       Impact factor: 6.048

4.  Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.

Authors:  L Vijaya; B N Mukhesh; B Shantha; S Ramalingam; A V Sathi Devi
Journal:  Ophthalmic Surg Lasers       Date:  2000 Jan-Feb

5.  Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts.

Authors:  J G Crowston; A N Akbar; P H Constable; N L Occleston; J T Daniels; P T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-02       Impact factor: 4.799

6.  Surgical management of post-traumatic angle recession glaucoma.

Authors:  A Mermoud; J F Salmon; A Barron; C Straker; A D Murray
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

7.  A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population.

Authors:  P R Egbert; A S Williams; K Singh; P Dadzie; T B Egbert
Journal:  Am J Ophthalmol       Date:  1993-11-15       Impact factor: 5.258

8.  Intraoperative 5-Fluorouracil administration in trabeculectomy.

Authors:  R M Feldman; P J Dietze; R L Gross; O Oram
Journal:  J Glaucoma       Date:  1994       Impact factor: 2.503

9.  Intra-operative use of 5-fluorouracil in glaucoma filtering surgery.

Authors:  I A Cunliffe; S Longstaff
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-12

10.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.